[HTML][HTML] Prevalence, awareness, treatment and control of dyslipidemia in older persons in urban and rural population in the Astana region, Kazakhstan

A Supiyev, T Nurgozhin, Z Zhumadilov, A Peasey… - BMC Public Health, 2017 - Springer
Background Despite high cardiovascular mortality in Central Asian republics of the former
Soviet Union, there is limited information about major risk factors, including blood lipids. We …

Dyslipidemia and its risk factors among urban middle-aged Iranians: A population-based study

H Ebrahimi, MH Emamian, H Hashemi… - Diabetes & Metabolic …, 2016 - Elsevier
Aims Dyslipidemia is a known risk factor for cardiovascular disease and is a leading cause
of mortality in developed and developing countries. This study was aimed to determine the …

Socioeconomic and geographic variations in the prevalence, awareness, treatment and control of dyslipidemia in middle-aged and older Chinese

P Song, M Zha, X Yang, Y Xu, H Wang, Z Fang, X Yang… - Atherosclerosis, 2019 - Elsevier
Background and aims Unevenly socioeconomic development and nutrition transition might
bring large variations in the epidemiology of dyslipidemia. We aimed to estimate the …

[HTML][HTML] Severe dyslipidemia and concomitant risk factors in the middle-aged Lithuanian adults: a cross-sectional cohort study

S Kutkienė, Ž Petrulionienė, A Laucevičius… - Lipids in health and …, 2018 - Springer
Background Dyslipidemia is highly prevalent and is one of the major risk factors for
cardiovascular disease in Lithuania. The purpose of this study was to determine the …

[PDF][PDF] Trends in main cardiovascular risk factors among middle-aged Kaunas population between 1983 and 2002

S Domarkienė, A Tamošiūnas, OR Rėklaitienė… - Medicina, 2003 - danacol.lt
Objective of the study–to evaluate dynamics in prevalence of main risk factors of
cardiovascular diseases among middle-aged Kaunas population between 1993 and 2002 …

Prevalence of dyslipidemia and associated risk factors in Turkish adults

F Bayram, D Kocer, K Gundogan, A Kaya… - Journal of clinical …, 2014 - Elsevier
Background and Objectives Dyslipidemia is a modifiable major risk factor for coronary heart
disease. The objective of this study was to determine the prevalence of dyslipidemia among …

The prevalence, awareness, treatment and control of dyslipidemia among adults in China

L Pan, Z Yang, Y Wu, RX Yin, Y Liao, J Wang, B Gao… - Atherosclerosis, 2016 - Elsevier
Objectives To analyze the prevalence, awareness, treatment, control and epidemiological
characteristics of dyslipidemia in Chinese adults. Methods In this cross-sectional study, we …

[HTML][HTML] The prevalence of hyperlipidemia among older people, Bushehr Elderly Health (BEH) program

A Ostovar, Z Fereidooni, A Ansari… - Iranian South Medical …, 2017 - ismj.bpums.ac.ir
Background: Life expectancy continues to increase and Iran's older population grows
dramatically. Old age is the strongest risk factor for developing atherosclerotic …

Prevalence, awareness, treatment and control of dyslipidaemia and their determinants: results from a population-based survey of 60 283 residents in eastern China

Y Chen, J Du, N Zhou, Y Song, W Wang, X Hong - BMJ open, 2023 - bmjopen.bmj.com
Objectives To investigate the prevalence, awareness, treatment and control of dyslipidaemia
and its associated factors in eastern China. Design Cross-sectional study. Setting Data were …

Changes in the prevalence, treatment, and control of hypercholesterolemia and other dyslipidemias over 10 years in Poland: the WOBASZ study

A Pająk, K Szafraniec, M Polak… - Polskie Archiwum …, 2017 - publicum.umed.lodz.pl
INTRODUCTION Lowering exposure to dyslipidemias is one of the biggest challenges in
cardiovascular disease prevention. OBJECTIVES The aim of the study was to describe the …